• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[F]AlF-NOTA-NOC 的制备与评价及其用于神经内分泌肿瘤 PET 成像的研究:与 [Ga]Ga-DOTA/NOTA-NOC 的比较。

Preparation and Evaluation of [F]AlF-NOTA-NOC for PET Imaging of Neuroendocrine Tumors: Comparison to [Ga]Ga-DOTA/NOTA-NOC.

机构信息

Department of Nuclear Medicine, Odense University Hospital, Kløvervænget 47, DK-5000 Odense, Denmark.

Department of Clinical Research, University of Southern Denmark, J.B. Winsløws Vej 19, DK-5000 Odense, Denmark.

出版信息

Molecules. 2022 Oct 12;27(20):6818. doi: 10.3390/molecules27206818.

DOI:10.3390/molecules27206818
PMID:36296411
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9609173/
Abstract

BACKGROUND

The somatostatin receptors 1-5 are overexpressed on neuroendocrine neoplasms and, as such, represent a favorable target for molecular imaging. This study investigates the potential of [F]AlF-NOTA-[1-Nal]-Octreotide and compares it in vivo to DOTA- and NOTA-[1-Nal]-Octreotide radiolabeled with gallium-68.

METHODS

DOTA- and NOTA-NOC were radiolabeled with gallium-68 and NOTA-NOC with [F]AlF. Biodistributions of the three radioligands were evaluated in AR42J xenografted mice at 1 h p.i and for [F]AlF at 3 h p.i. Preclinical PET/CT was applied to confirm the general uptake pattern.

RESULTS

Gallium-68 was incorporated into DOTA- and NOTA-NOC in yields and radiochemical purities greater than 96.5%. NOTA-NOC was radiolabeled with [F]AlF in yields of 38 ± 8% and radiochemical purity above 99% after purification. The biodistribution in tumor-bearing mice showed a high uptake in tumors of 26.4 ± 10.8 %ID/g for [Ga]Ga-DOTA-NOC and 25.7 ± 5.8 %ID/g for [Ga]Ga-NOTA-NOC. Additionally, [F]AlF-NOTA-NOC exhibited a tumor uptake of 37.3 ± 10.5 %ID/g for [F]AlF-NOTA-NOC, which further increased to 42.1 ± 5.3 %ID/g at 3 h p.i.

CONCLUSIONS

The high tumor uptake of all radioligands was observed. However, [F]AlF-NOTA-NOC surpassed the other clinically well-established radiotracers in vivo, especially at 3 h p.i. The tumor-to-blood and -liver ratios increased significantly over three hours for [F]AlF-NOTA-NOC, making it possible to detect liver metastases. Therefore, [F]AlF demonstrates promise as a surrogate pseudo-radiometal to gallium-68.

摘要

背景

生长抑素受体 1-5 在神经内分泌肿瘤中过度表达,因此成为分子成像的有利靶点。本研究探讨了 [F]AlF-NOTA-[1-Nal]-奥曲肽的潜力,并将其与镓-68 标记的 DOTA-和 NOTA-[1-Nal]-奥曲肽进行了体内比较。

方法

用镓-68 标记 DOTA-和 NOTA-NOC,用 [F]AlF 标记 NOTA-NOC。在 AR42J 异种移植瘤小鼠中,于 1 h p.i. 评估三种放射性配体的生物分布,并于 3 h p.i. 评估 [F]AlF 的生物分布。应用临床前 PET/CT 确认一般摄取模式。

结果

镓-68 以大于 96.5%的产率和放射化学纯度掺入 DOTA-和 NOTA-NOC。NOTA-NOC 用 [F]AlF 标记,产率为 38±8%,放射化学纯度大于 99%,经纯化后。荷瘤小鼠的生物分布显示,[Ga]Ga-DOTA-NOC 的肿瘤摄取率为 26.4±10.8%ID/g,[Ga]Ga-NOTA-NOC 的肿瘤摄取率为 25.7±5.8%ID/g。此外,[F]AlF-NOTA-NOC 的肿瘤摄取率为 37.3±10.5%ID/g,3 h p.i. 时进一步增加至 42.1±5.3%ID/g。

结论

观察到所有放射性配体的高肿瘤摄取。然而,[F]AlF-NOTA-NOC 在体内超过了其他临床上广泛应用的放射性示踪剂,特别是在 3 h p.i. 时。[F]AlF-NOTA-NOC 的肿瘤与血液和肝脏的比值在 3 小时内显著增加,这使得检测肝转移成为可能。因此,[F]AlF 有望成为镓-68 的替代拟放射性金属。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/824d/9609173/69e176d3992d/molecules-27-06818-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/824d/9609173/16373bb215bc/molecules-27-06818-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/824d/9609173/a45c3e6fdf97/molecules-27-06818-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/824d/9609173/69e176d3992d/molecules-27-06818-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/824d/9609173/16373bb215bc/molecules-27-06818-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/824d/9609173/a45c3e6fdf97/molecules-27-06818-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/824d/9609173/69e176d3992d/molecules-27-06818-g003.jpg

相似文献

1
Preparation and Evaluation of [F]AlF-NOTA-NOC for PET Imaging of Neuroendocrine Tumors: Comparison to [Ga]Ga-DOTA/NOTA-NOC.[F]AlF-NOTA-NOC 的制备与评价及其用于神经内分泌肿瘤 PET 成像的研究:与 [Ga]Ga-DOTA/NOTA-NOC 的比较。
Molecules. 2022 Oct 12;27(20):6818. doi: 10.3390/molecules27206818.
2
F-AlF-NOTA-Octreotide Outperforms Ga-DOTATATE/NOC PET in Neuroendocrine Tumor Patients: Results from a Prospective, Multicenter Study.F-AlF-NOTA-奥曲肽在神经内分泌肿瘤患者中优于Ga-DOTATATE/NOC PET:一项前瞻性多中心研究的结果
J Nucl Med. 2023 Apr;64(4):632-638. doi: 10.2967/jnumed.122.264563. Epub 2022 Oct 20.
3
Synthesis, preclinical evaluation, and a pilot clinical imaging study of [F]AlF-NOTA-JR11 for neuroendocrine neoplasms compared with [Ga]Ga-DOTA-TATE.[F]AlF-NOTA-JR11 的合成、临床前评估及用于神经内分泌肿瘤的初步临床成像研究与 [Ga]Ga-DOTA-TATE 的比较。
Eur J Nucl Med Mol Imaging. 2021 Sep;48(10):3129-3140. doi: 10.1007/s00259-021-05249-8. Epub 2021 Feb 25.
4
Clinical impact of using [F]AlF-NOTA-octreotide PET/CT instead of [Ga]Ga-DOTA-SSA PET/CT: Secondary endpoint analysis of a multicenter, prospective trial.使用[F]AlF-NOTA-奥曲肽PET/CT而非[Ga]Ga-DOTA-SSA PET/CT的临床影响:一项多中心前瞻性试验的次要终点分析
J Neuroendocrinol. 2024 Aug;36(8):e13420. doi: 10.1111/jne.13420. Epub 2024 Jun 4.
5
Development of novel peptide-based radiotracers for detecting PD-L1 expression and guiding cancer immunotherapy.新型基于肽的放射性示踪剂用于检测 PD-L1 表达和指导癌症免疫治疗的研究进展。
Eur J Nucl Med Mol Imaging. 2024 Feb;51(3):625-640. doi: 10.1007/s00259-023-06480-1. Epub 2023 Oct 25.
6
[F]AlF-NOTA-octreotide PET imaging: biodistribution, dosimetry and first comparison with [Ga]Ga-DOTATATE in neuroendocrine tumour patients.[F]AlF-NOTA-奥曲肽正电子发射断层显像:神经内分泌肿瘤患者的生物分布、剂量测定及与[Ga]Ga- DOTATATE的首次比较
Eur J Nucl Med Mol Imaging. 2020 Dec;47(13):3033-3046. doi: 10.1007/s00259-020-04918-4. Epub 2020 Jul 2.
7
3p-C-NETA: A versatile and effective chelator for development of AlF-labeled and therapeutic radiopharmaceuticals.3p-C-NETA:一种多功能、有效的螯合剂,可用于开发 AlF 标记的治疗放射性药物。
Theranostics. 2022 Aug 8;12(13):5971-5985. doi: 10.7150/thno.75336. eCollection 2022.
8
Direct comparison of [F]AlF-NOTA-JR11 and [F]AlF-NOTA-octreotide for PET imaging of neuroendocrine tumors: Antagonist versus agonist.直接比较 [F]AlF-NOTA-JR11 和 [F]AlF-NOTA-奥曲肽用于神经内分泌肿瘤的 PET 成像:拮抗剂与激动剂。
Nucl Med Biol. 2023 Mar-Apr;118-119:108338. doi: 10.1016/j.nucmedbio.2023.108338. Epub 2023 Mar 29.
9
Evaluation of the safety, biodistribution, dosimetry of [F]AlF-NOTA-LM3 and head-to-head comparison with [Ga]Ga-DOTATATE in patients with well-differentiated neuroendocrine tumors: an interim analysis of a prospective trial.[F]AlF-NOTA-LM3在高分化神经内分泌肿瘤患者中的安全性、生物分布、剂量测定评估以及与[Ga]Ga-DOTATATE的头对头比较:一项前瞻性试验的中期分析
Eur J Nucl Med Mol Imaging. 2024 Oct;51(12):3719-3730. doi: 10.1007/s00259-024-06790-y. Epub 2024 Jun 15.
10
In Vivo Evaluation and Dosimetry Estimate for a High Affinity Affibody PET Tracer Targeting PD-L1.针对 PD-L1 的高亲和力亲和体 PET 示踪剂的体内评估和剂量估算。
Mol Imaging Biol. 2021 Apr;23(2):241-249. doi: 10.1007/s11307-020-01544-2. Epub 2020 Oct 23.

引用本文的文献

1
Side by side comparison of NOTA and DOTA for conjugation efficiency, gallium-68 labeling, and in vivo biodistribution of anti-mesothelin sdAb A1-His.用于比较NOTA和DOTA在抗间皮素单域抗体A1-His的偶联效率、镓-68标记及体内生物分布方面的并排比较。
EJNMMI Radiopharm Chem. 2025 Aug 20;10(1):54. doi: 10.1186/s41181-025-00380-5.
2
Superior lesion detection with F-AlF-NOTA-octreotide PET/CT compared to I-MIBG SPECT/CT in neuroblastoma.与I-MIBG SPECT/CT相比,F-AlF-NOTA-奥曲肽PET/CT在神经母细胞瘤中具有更高的病灶检测能力。
Quant Imaging Med Surg. 2025 Aug 1;15(8):6948-6958. doi: 10.21037/qims-24-2456. Epub 2025 Jul 30.
3

本文引用的文献

1
Multi-curie production of gallium-68 on a biomedical cyclotron and automated radiolabelling of PSMA-11 and DOTATATE.在生物医学回旋加速器上进行多居里镓-68的生产以及PSMA-11和DOTATATE的自动放射性标记。
EJNMMI Radiopharm Chem. 2021 Jan 7;6(1):1. doi: 10.1186/s41181-020-00114-9.
2
The battle on time, money and precision: Da[F] id vs. [Ga]liath.时间、金钱与精准度之战:大卫对阵歌利亚。 (注:这里的[F]、[Ga]可能是原文中特定的指代或错误标注,不影响整体理解,按正常翻译即可)
Eur J Nucl Med Mol Imaging. 2020 Dec;47(13):2944-2946. doi: 10.1007/s00259-020-04961-1.
3
The Current Status of the Production and Supply of Gallium-68.
Optimization of a GMP-compliant automated one-pot synthesis of Al[F]F-NOTA-Ubiquicidin for bacterial infection imaging by PET/CT.
用于PET/CT细菌感染成像的符合GMP标准的Al[F]F-NOTA-泛喹杀菌素自动化一锅法合成的优化。
EJNMMI Radiopharm Chem. 2025 Jul 28;10(1):48. doi: 10.1186/s41181-025-00370-7.
4
The clinical benefits of [F]AlF-NOTA-octreotide PET/CT in staging and restaging patients with gastroenteropancreatic neuroendocrine neoplasms: comparison of [F]FDG PET/CT.[F]AlF-NOTA-奥曲肽PET/CT在胃肠胰神经内分泌肿瘤患者分期及再分期中的临床应用:与[F]FDG PET/CT的比较
BMC Med Imaging. 2025 Jul 11;25(1):280. doi: 10.1186/s12880-025-01824-9.
5
Evaluation of [F]AlF NOTA-5G, an Aluminum [F]fluoride Labeled Peptide Targeting the Cell Surface Receptor Integrin Alpha(v)beta(6) for PET Imaging.用于正电子发射断层显像(PET)成像的靶向细胞表面受体整合素α(v)β(6)的铝[F]氟化物标记肽[F]AlF NOTA-5G的评估。
Mol Imaging Biol. 2025 Apr;27(2):285-292. doi: 10.1007/s11307-025-01989-3. Epub 2025 Feb 20.
镓-68 的生产和供应现状。
Cancer Biother Radiopharm. 2020 Apr;35(3):163-166. doi: 10.1089/cbr.2019.3301. Epub 2020 Mar 20.
4
Automated GMP compliant production of [F]AlF-NOTA-octreotide.符合药品生产质量管理规范(GMP)的[F]AlF-NOTA-奥曲肽自动化生产。
EJNMMI Radiopharm Chem. 2020 Jan 29;5(1):4. doi: 10.1186/s41181-019-0084-1.
5
Biodistribution and first clinical results of F-SiFAlin-TATE PET: a novel F-labeled somatostatin analog for imaging of neuroendocrine tumors.F-SiFAlin-TATE PET的生物分布及首次临床结果:一种用于神经内分泌肿瘤成像的新型F标记生长抑素类似物。
Eur J Nucl Med Mol Imaging. 2020 Apr;47(4):870-880. doi: 10.1007/s00259-019-04501-6. Epub 2019 Sep 6.
6
Microscale radiosynthesis, preclinical imaging and dosimetry study of [F]AMBF-TATE: A potential PET tracer for clinical imaging of somatostatin receptors.微尺度放射性合成、[F]AMBF-TATE 的临床前成像和剂量学研究:一种用于生长抑素受体临床成像的潜在 PET 示踪剂。
Nucl Med Biol. 2018 Jun;61:36-44. doi: 10.1016/j.nucmedbio.2018.04.001. Epub 2018 Apr 20.
7
Production of novel diagnostic radionuclides in small medical cyclotrons.小型医用回旋加速器中新型诊断放射性核素的生产。
EJNMMI Radiopharm Chem. 2018;3(1):3. doi: 10.1186/s41181-018-0038-z. Epub 2018 Feb 20.
8
Effect of hormone secretory syndromes on neuroendocrine tumor prognosis.激素分泌综合征对神经内分泌肿瘤预后的影响。
Endocr Relat Cancer. 2017 Jul;24(7):R261-R274. doi: 10.1530/ERC-16-0538. Epub 2017 May 8.
9
Phase 3 Trial of Lu-Dotatate for Midgut Neuroendocrine Tumors.镥[177Lu]奥曲肽治疗中肠神经内分泌肿瘤的3期试验
N Engl J Med. 2017 Jan 12;376(2):125-135. doi: 10.1056/NEJMoa1607427.
10
In Vivo Evaluation of a Bombesin Analogue Labeled with Ga-68 and Co-55/57.用Ga-68和Co-55/57标记的蛙皮素类似物的体内评估
Mol Imaging Biol. 2016 Jun;18(3):368-76. doi: 10.1007/s11307-015-0911-z.